Patents by Inventor Andrew J. Hoteling
Andrew J. Hoteling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11897985Abstract: A water extractable ophthalmic device is disclosed which is a polymerization product of a monomeric mixture comprising: (a) one or more cyclic lactams; (b) one or more non-bulky organosilicon-containing monomers; (c) one or more bulky siloxane monomers; and (d) a crosslinking agent mixture comprising (i) one or more first crosslinking agents containing at least two ethylenically unsaturated reactive end groups, wherein the at least two ethylenically unsaturated reactive end groups are (meth)acrylate-containing reactive end groups and (ii) one or more second crosslinking agents containing at least two ethylenically unsaturated reactive end groups wherein at least one of the ethylenically unsaturated reactive end groups is a non-(meth)acrylate reactive end group. The water extractable ophthalmic device has an equilibrium water content of at least about 50 wt. %, a contact angle of less than about 50°, and an oxygen permeability of at least about 60 Barrers.Type: GrantFiled: April 26, 2022Date of Patent: February 13, 2024Assignee: Bausch & Lomb IncorporatedInventors: Ivan M. Nuñez, Lynn Coullard, Analuz Mark, Andrew J. Hoteling, Joseph W. Hoff
-
Publication number: 20230407077Abstract: A grafted glycosaminoglycan polymer is disclosed. The grafted glycosaminoglycan polymer comprises a glycosaminoglycan having a polymer backbone and one or more side chains comprising a polyalkylene glycol-containing residue grafted onto the polymer backbone.Type: ApplicationFiled: September 6, 2023Publication date: December 21, 2023Inventors: James Anthony DiBella, JR., Alok Kumar Awasthi, Jade J. Russell, Mark R. Mis, James Hauenstein, Mark Fomalik, Andrew J. Hoteling, Shawn M. Conlon, Kaushiendra Kumar
-
Patent number: 11795320Abstract: A grafted glycosaminoglycan polymer is disclosed. The grafted glycosaminoglycan polymer comprises a glycosaminoglycan having a polymer backbone and one or more side chains comprising a polyalkylene glycol-containing residue grafted onto the polymer backbone.Type: GrantFiled: September 16, 2020Date of Patent: October 24, 2023Assignee: BAUSCH + LOMB IRELAND LIMITEDInventors: James Anthony DiBella, Jr., Alok Kumar Awasthi, Jade J. Russell, Mark R. Mis, James Hauenstein, Mark Fornalik, Andrew J. Hoteling, Shawn M. Conlon, Kaushlendra Kumar
-
Publication number: 20220288270Abstract: A packaging system for the storage of an ophthalmic device is disclosed. The packaging system includes a sealed container containing one or more unused ophthalmic devices immersed in an aqueous packaging solution that includes one or more conjugated glycosaminoglycans having a polymer backbone having a reactive functional moiety conjugated to an amine group having one or more moieties that inhibit and/or prevent one or more of oxidation and hydrolytic degradation of the polymer backbone during use in the eye; wherein the aqueous packaging solution has an osmolality of at least about 150 mOsm/kg, a pH of about 6 to about 9 and is sterilized.Type: ApplicationFiled: March 8, 2022Publication date: September 15, 2022Inventors: Katie L. Poetz, Ivan M. Nuñez, Analuz Mark, Grace Bennett, Robert Steffen, Andrew J. Hoteling, Michelle Piotrowski, Brendan Shannon, Keyla Cubi, Alana Ingham
-
Publication number: 20220251269Abstract: A water extractable ophthalmic device is disclosed which is a polymerization product of a monomeric mixture comprising: (a) one or more cyclic lactams; (b) one or more non-bulky organosilicon-containing monomers; (c) one or more bulky siloxane monomers; and (d) a crosslinking agent mixture comprising (i) one or more first crosslinking agents containing at least two ethylenically unsaturated reactive end groups, wherein the at least two ethylenically unsaturated reactive end groups are (meth)acrylate-containing reactive end groups and (ii) one or more second crosslinking agents containing at least two ethylenically unsaturated reactive end groups wherein at least one of the ethylenically unsaturated reactive end groups is a non-(meth)acrylate reactive end group. The water extractable ophthalmic device has an equilibrium water content of at least about 50 wt. %, a contact angle of less than about 50°, and an oxygen permeability of at least about 60 Barrers.Type: ApplicationFiled: April 26, 2022Publication date: August 11, 2022Inventors: Ivan M. Nuñez, Lynn Coullard, Analuz Mark, Andrew J. Hoteling, Joseph W. Hoff
-
Patent number: 11345773Abstract: A water extractable ophthalmic device is disclosed which is a polymerization product of a monomeric mixture comprising: (a) one or more cyclic lactams; (b) one or more non-bulky organosilicon-containing monomers; (c) one or more bulky siloxane monomers; and (d) a crosslinking agent mixture comprising (i) one or more first crosslinking agents containing at least two ethylenically unsaturated reactive end groups, wherein the at least two ethylenically unsaturated reactive end groups are (meth)acrylate-containing reactive end groups and (ii) one or more second crosslinking agents containing at least two ethylenically unsaturated reactive end groups wherein at least one of the ethylenically unsaturated reactive end groups is a non-(meth)acrylate reactive end group. The water extractable ophthalmic device has an equilibrium water content of at least about 50 wt. %, a contact angle of less than about 50°, and an oxygen permeability of at least about 60 Barrers.Type: GrantFiled: April 5, 2019Date of Patent: May 31, 2022Assignee: Bausch & Lomb IncorporatedInventors: Ivan M. Nuñez, Lynn Coullard, Analuz Mark, Andrew J. Hoteling, Joseph W. Hoff
-
Patent number: 11022722Abstract: A water extractable ophthalmic device is disclosed which is a polymerization product of a monomeric mixture comprising: (a) one or more cyclic lactams; (b) one or more organosilicon-containing block copolymers; (c) one or more bulky siloxane monomers; and (d) a crosslinking agent mixture comprising (i) one or more first crosslinking agents containing at least two ethylenically unsaturated reactive end groups, wherein the at least two ethylenically unsaturated reactive end groups are (meth)acrylate-containing reactive end groups and (ii) one or more second crosslinking agents containing at least two ethylenically unsaturated reactive end groups wherein at least one of the ethylenically unsaturated reactive end groups is a non-(meth)acrylate reactive end group. The water extractable ophthalmic device has an equilibrium water content of at least about 50 wt. %, a contact angle of less than about 50°, and an oxygen permeability of at least about 60 Barrers.Type: GrantFiled: May 17, 2019Date of Patent: June 1, 2021Assignee: Bausch & Lomb IncorporatedInventors: Ivan M. Nuñez, Katie L. Poetz, Lynn Coullard, Alok Kumar Awasthi, Analuz Mark, Joseph W. Hoff, Andrew J. Hoteling
-
Publication number: 20210087384Abstract: A grafted glycosaminoglycan polymer is disclosed. The grafted glycosaminoglycan polymer comprises a glycosaminoglycan having a polymer backbone and one or more side chains comprising a polyalkylene glycol-containing residue grafted onto the polymer backbone.Type: ApplicationFiled: September 16, 2020Publication date: March 25, 2021Inventors: James Anthony DiBella, JR., Alok K. Alwasthi, Jade J. Russell, Mark R. Mis, James Hauenstein, Mark Fornalik, Andrew J. Hoteling, Shawn M. Conlon, Kaushlendra Kumar
-
Patent number: 10870731Abstract: A method is disclosed which involves the steps of (a) reacting a polysiloxane prepolymer having reactive functional end groups with a non-free radical polymerizable reactive end-capping agent; and (b) reacting the reaction product of step (a) with a free radical polymerizable reactive end-capping agent.Type: GrantFiled: January 14, 2019Date of Patent: December 22, 2020Assignee: Bausch & Lomb IncorporatedInventors: Ivan M. Nuñez, Katie L. Poetz, Andrew J. Hoteling, Joseph W. Hoff, Lynn Coullard, Analuz Mark, Keyla M. Cubi, Joseph A. McGee
-
Publication number: 20200012015Abstract: A water extractable ophthalmic device is disclosed which is a polymerization product of a monomeric mixture comprising: (a) one or more cyclic lactams; (b) one or more organosilicon-containing block copolymers; (c) one or more bulky siloxane monomers; and (d) a crosslinking agent mixture comprising (i) one or more first crosslinking agents containing at least two ethylenically unsaturated reactive end groups, wherein the at least two ethylenically unsaturated reactive end groups are (meth)acrylate-containing reactive end groups and (ii) one or more second crosslinking agents containing at least two ethylenically unsaturated reactive end groups wherein at least one of the ethylenically unsaturated reactive end groups is a non-(meth)acrylate reactive end group. The water extractable ophthalmic device has an equilibrium water content of at least about 50 wt. %, a contact angle of less than about 50°, and an oxygen permeability of at least about 60 Barrers.Type: ApplicationFiled: May 17, 2019Publication date: January 9, 2020Inventors: Ivan M. Nuñez, Katie L. Poetz, Lynn Coullard, Alok Kumar Awasfhi, Analuz Mark, Joseph W. Hoff, Andrew J. Hoteling
-
Publication number: 20190352443Abstract: A water extractable ophthalmic device is disclosed which is a polymerization product of a monomeric mixture comprising: (a) one or more cyclic lactams; (b) one or more non-bulky organosilicon-containing monomers; (c) one or more bulky siloxane monomers; and (d) a crosslinking agent mixture comprising (i) one or more first crosslinking agents containing at least two ethylenically unsaturated reactive end groups, wherein the at least two ethylenically unsaturated reactive end groups are (meth)acrylate-containing reactive end groups and (ii) one or more second crosslinking agents containing at least two ethylenically unsaturated reactive end groups wherein at least one of the ethylenically unsaturated reactive end groups is a non-(meth)acrylate reactive end group. The water extractable ophthalmic device has an equilibrium water content of at least about 50 wt. %, a contact angle of less than about 50°, and an oxygen permeability of at least about 60 Barrers.Type: ApplicationFiled: April 5, 2019Publication date: November 21, 2019Inventors: Ivan M. Nuñez, Lynn Coullard, Analuz Mark, Andrew J. Hoteling, Joseph W. Hoff
-
Publication number: 20190233593Abstract: A method is disclosed which involves the steps of (a) reacting a polysiloxane prepolymer having reactive functional end groups with a non-free radical polymerizable reactive end-capping agent; and (b) reacting the reaction product of step (a) with a free radical polymerizable reactive end-capping agent.Type: ApplicationFiled: January 14, 2019Publication date: August 1, 2019Inventors: Ivan M. Nuñez, Katie L. Poetz, Andrew J. Hoteling, Joseph W. Hoff, Lynn Coullard, Analuz Mark, Keyla M. Cubi, Joseph A. McGee
-
Patent number: 8012915Abstract: The present invention is a release oil of the general formulae: wherein (Z) is an amine. The solvent extracted portion of the release oil has a ratio of A:B less than 1:5. Less than 10% of the molecular weight distribution of the release oil is less than m/z 1000. The release oil preferably has a viscosity of between 200 and 500 centistokes.Type: GrantFiled: October 19, 2007Date of Patent: September 6, 2011Assignee: Eastman Kodak CompanyInventors: Wayne T. Ferrar, Jerry A. Pickering, David F. Cahill, Peter S. Alexandrovich, Andrew J. Hoteling
-
Patent number: 7628849Abstract: Fluorinated bis-(phthalocyanylaluminoxy)silyl bridged cyan or blue-green pigments according to formula (I): wherein R1 and R2 are independently substituted or unsubstituted alkyl, alkenyl, alkynyl, or cycloalkyl groups with eight or less carbon atoms or aryl groups with ten or less carbon atoms; R3 is a divalent linking group comprising oxygen, R1R2Si, substituted or unsubstituted alkyl, alkenyl, alkynyl cycloalkyl or aryl groups; R1, R2, and R3 may comprise the elements of a cyclic ring; n is 1-4; and z is 1-4.Type: GrantFiled: October 29, 2008Date of Patent: December 8, 2009Assignee: Eastman Kodak CompanyInventors: Donald R. Diehl, Tommie L. Royster, Jr., Andrew J. Hoteling, Steven G. Link
-
Publication number: 20090105100Abstract: The present invention is a release oil of the general formulae: wherein (Z) is an amine. The solvent extracted portion of the release oil has a ratio of A:B less than 1:5. Less than 10% of the molecular weight distribution of the release oil is less than m/z 1000. The release oil preferably has a viscosity of between 200 and 500 centistokes.Type: ApplicationFiled: October 19, 2007Publication date: April 23, 2009Inventors: Wayne T. Ferrar, Jerry A. Pickering, David F. Cahill, Peter S. Alexandrovich, Andrew J. Hoteling